Related Experiment Video
Updated: Jul 14, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Strategies to Get Drugs across Bladder Penetrating Barriers for Improving Bladder Cancer Therapy
Shupeng Wang1, Shaohua Jin1, Qinghai Shu1
1School of Material Science and Engineering, Beijing Institute of Technology, Beijing 100081, China.
Abstract:
Bladder cancer is a significant public health concern and social burden due to its high recurrence risk. Intravesical drug instillation is the primary therapy for bladder cancer to prevent recurrence. However, the intravesical drug therapeutic effect is limited by bladder penetrating barriers. The inadequate intravesical treatment might cause the low drug concentration in lesions, resulting in a high recurrence/progression rate of bladder cancer. Many strategies to get drugs across bladder penetrating barriers have been developed to improve intravesical treatment, including physical and chemical methods. This review summarizes the classical and updated literature and presents insights into great therapeutic potential strategies to overcome bladder penetrating barriers for improving the intravesical treatment of bladder cancer.
Insights
Bladder cancer treatment faces challenges due to barriers limiting drug penetration. This review explores strategies to enhance intravesical drug delivery, aiming to reduce cancer recurrence.
Area of Science:
- Oncology
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Bladder cancer presents a significant public health challenge, characterized by high recurrence rates.
- Intravesical drug instillation is a standard therapy for bladder cancer, yet its efficacy is hampered by the bladder's natural barriers.
- Insufficient drug penetration leads to low concentrations at tumor sites, contributing to cancer recurrence and progression.
Purpose of the Study:
- To review existing literature on strategies for overcoming bladder penetration barriers in intravesical therapy.
- To highlight novel and classical methods for enhancing drug delivery across the bladder wall.
- To discuss the therapeutic potential of these strategies for improving bladder cancer treatment outcomes.
Main Methods:
- Comprehensive literature search of classical and recent studies on intravesical drug delivery for bladder cancer.
- Categorization of strategies into physical and chemical methods for enhancing drug penetration.
- Analysis of the efficacy and potential of various approaches to overcome bladder barriers.
Main Results:
- Identified physical methods (e.g., ultrasound, iontophoresis) and chemical methods (e.g., permeation enhancers, nanoparticles) to improve drug transport.
- Demonstrated that overcoming bladder barriers can significantly increase drug concentration in bladder tissues.
- Highlighted the potential of advanced drug delivery systems to enhance therapeutic efficacy.
Conclusions:
- Strategies to overcome bladder penetration barriers are crucial for improving intravesical chemotherapy effectiveness.
- Enhanced drug delivery holds significant promise for reducing bladder cancer recurrence and progression.
- Further research into optimized delivery systems can revolutionize bladder cancer management.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Drug Elimination by Renal Route: Tubular Reabsorption
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Bioavailability Enhancement: Drug Permeability Enhancement
Urinary Tract Calculi III: Medical Management